Literature DB >> 23800801

Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection.

Astrid Godron1, Sabine Pereyre, Catherine Monet, Brigitte Llanas, Jérôme Harambat.   

Abstract

BACKGROUND: Mycoplasma pneumoniae can cause various extrapulmonary manifestations but, to our knowledge, no case of Mycoplasma pneumoniae associated with hemolytic uremic syndrome (HUS) has been reported. CASE-DIAGNOSIS/TREATMENT: We describe a 1-year-old boy with M. pneumoniae respiratory tract infection and associated microangiopathic hemolytic anemia, slightly decreased platelet count and mild renal impairment, suggesting a diagnosis of HUS. Assuming M. pneumoniae infection was the cause of HUS in this case, the different possible mechanisms, including an atypical HUS due to preexisting complement dysregulation, an alternative complement pathway activation induced by M. pneumoniae infection at the acute phase, an autoimmune disorder, and a direct role of the bacteria in inducing endothelial injury, are discussed. The signs of HUS resolved with treatment of the M. pneumoniae infection.
CONCLUSIONS: Hemolytic uremic syndrome may be an unusual complication of M. pneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23800801     DOI: 10.1007/s00467-013-2541-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

1.  Favorable outcome in a case of Mycoplasma pneumoniae-associated crescentic glomerulonephritis.

Authors:  Anne-Laure Adra; Marie-Gabrielle Vigue; Fabienne Dalla Vale; Lydia Ichay; Pierre Raynaud; Aude Mariani; Denis Morin
Journal:  Pediatr Nephrol       Date:  2010-03-25       Impact factor: 3.714

2.  Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

Authors:  Gema Ariceta; Nesrin Besbas; Sally Johnson; Diana Karpman; Daniel Landau; Christoph Licht; Chantal Loirat; Carmine Pecoraro; C Mark Taylor; Nicole Van de Kar; Johan Vandewalle; Lothar B Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2008-09-18       Impact factor: 3.714

3.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

4.  Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger?

Authors:  Upton Allen; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2010-11-07       Impact factor: 3.714

Review 5.  A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.

Authors:  N Besbas; D Karpman; D Landau; C Loirat; W Proesmans; G Remuzzi; G Rizzoni; C M Taylor; N Van de Kar; L B Zimmerhackl
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

6.  Streptococcus pneumoniae--associated hemolytic uremic syndrome: classification and the emergence of serotype 19A.

Authors:  Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatrics       Date:  2009-12-21       Impact factor: 7.124

Review 7.  Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia.

Authors:  Mitsuo Narita
Journal:  J Infect Chemother       Date:  2010-02-27       Impact factor: 2.211

8.  Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood.

Authors:  M M Fitzpatrick; M D Walters; R S Trompeter; M J Dillon; T M Barratt
Journal:  J Pediatr       Date:  1993-04       Impact factor: 4.406

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Retrospective survey for sialidase activity in Mycoplasma pneumoniae isolates from cases of community-acquired pneumonia.

Authors:  Meghan May; Daniel R Brown
Journal:  BMC Res Notes       Date:  2011-06-15
View more
  3 in total

Review 1.  Mycoplasma pneumoniae Infections and Primary Immune Deficiencies.

Authors:  Dimitri Poddighe; Erkan Demirkaya; Vitaliy Sazonov; Micol Romano
Journal:  Int J Clin Pract       Date:  2022-07-08       Impact factor: 3.149

Review 2.  Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment.

Authors:  Sabine Pereyre; Julien Goret; Cécile Bébéar
Journal:  Front Microbiol       Date:  2016-06-22       Impact factor: 5.640

Review 3.  Thrombosis associated with mycoplasma pneumoniae infection (Review).

Authors:  Jingwei Liu; Yumei Li
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.